drugset / Trial / NCT00800423

Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema

NCT00800423

Phase 3 Unknown 150 enrolled Rabin Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Most patients undergoing cataract surgery suffer from corneal edema after the surgery. Brimonidine drops are a well known and safe Anti-glaucoma medication. the investigators have made several clinical observations that patients receiving Brimonidine drops had a faster resolution of their corneal edema even if they had normal intra-ocular pressure. The investigators believe that administering topical Brimonidine to patients with significant post operative corneal edema will hasten the resolution of their corneal edema.

Timeline

Start
2009-01
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule 0.2 % Topical
Comparator Timolol Other / unclassified 0.5 % Topical

Indications